Harni N

Harnin Biotech is a clinical-stage biotechnology company specializing in the development of mRNA-based therapeutics and vaccines. The company leverages a proprietary mRNA-LNP (lipid nanoparticle) delivery platform to design treatments for oncology, infectious diseases, and rare genetic disorders. Their pipeline includes innovative mRNA candidates aimed at modulating the immune system through the expression of cytokines and growth factors. Harnin Biotech focuses on optimizing the stability and tissue-specific delivery of mRNA to improve therapeutic efficacy and safety profiles. The company is actively advancing its lead programs toward clinical trials while expanding its technological capabilities through strategic research collaborations.